Children should be taught to make a distinction between the advances of a stranger who intends harm and the availability of ones who can help.
Incorporating objective testing to add value to an ADHD diagnosis
Perry Roy, MD, explains how an FDA-cleared objective test can assist in an ADHD diagnosis.
Food Insecurity and the Dangers of Infant Formula Dilution
FDA approves tovorafenib for most common form of childhood brain tumor
This decision from the federal agency marks the first FDA approval of a systemic therapy to treat patients with pediatric LGG with BRAF rearrangements, including fusions.
Demystifying Infant Formula
Ustekinumab biosimilar approved to treat moderate to severe plaque psoriasis
The biosimilar to ustekinumab is approved for patients 6 years and up, and is expected to be marketed on or after February 21, 2025.
CRL issued for pz-cel as potential recessive dystrophic epidermolysis bullosa treatment
Abeona's pz-cel is up for indicated use to treat patients with recessive dystrophic epidermolysis bullosa.